Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
US Department of Justice
Fish and Richardson
AstraZeneca
Novartis
Queensland Health
Mallinckrodt
Medtronic
Daiichi Sankyo
Farmers Insurance

Generated: January 23, 2018

DrugPatentWatch Database Preview

SOMOPHYLLIN-CRT Drug Profile

« Back to Dashboard

Which patents cover Somophyllin-crt, and when can generic versions of Somophyllin-crt launch?

Somophyllin-crt is a drug marketed by Graham Dm and is included in five NDAs.

The generic ingredient in SOMOPHYLLIN-CRT is theophylline. There are thirty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the theophylline profile page.

US Patents and Regulatory Information for SOMOPHYLLIN-CRT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 087763-001 Feb 27, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 087193-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 087194-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 088382-001 Feb 27, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Graham Dm SOMOPHYLLIN-CRT theophylline CAPSULE, EXTENDED RELEASE;ORAL 088383-001 Feb 27, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Fuji
Cipla
Colorcon
Moodys
Novartis
Daiichi Sankyo
Chinese Patent Office
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot